Evaluation of the clinical efficacy of 1.2% atorvastatin in the treatment of periodontal intraosseous defects by CBCT: A randomized controlled clinical trial.

J Dent Res Dent Clin Dent Prospects · 2019 · PMC6904913 · PMID 31857864

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Results Clinical Parameters In the present split-mouth study, there was a highly significant reduction in the PI and mSBI at 3 and 6 months.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.